市场调查报告书
商品编码
1491618
全球血压计市场:按产品、最终用途、分销管道 - 预测 2024-2030Blood Pressure Monitors Market by Product, End-use, Distribution Channel - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球血压计市场规模为44.6亿美元,预计2024年将达48.1亿美元,2030年将达到75.4亿美元,复合年增长率为7.77%。
血压计是用来测量人体动脉血压的设备。这些设备通常提供两个重要资讯:收缩压和舒张压。收缩压是心臟跳动和泵血时动脉中的最高血压,舒张压是心臟在两次跳动之间休息时的最低血压。由于人口老化、肥胖和久坐的生活方式导致全球高血压盛行率不断上升,推动了全球血压计市场的成长。预防性医疗保健的趋势也在不断增长,个人在管理自己的健康方面变得更加积极主动。人们对高血压早期诊断和早期管理重要性的认识不断提高,推动了家用血压计在全球的使用,进一步推动了市场需求。然而,由于功能缺陷和安全问题,全球血压计市场一直受到产品召回事件的案例。此类召回会给製造商带来直接的经济损失,并降低消费者对这些设备的信心。血压计领域先进的感测器技术为市场扩张提供了巨大的机会。这些技术进步可以提供即时回馈并监控随时间的变化,从而为家庭和临床使用带来更易于使用和更有效率的设备。
主要市场统计 | |
---|---|
基准年[2023] | 44.6亿美元 |
预测年份 [2024] | 48.1亿美元 |
预测年份 [2030] | 75.4亿美元 |
复合年增长率(%) | 7.77% |
区域洞察
在美洲,由于高血压和其他心血管疾病的流行,人们对血压监测重要性的高度认识正在推动全球血压计市场的成长。在美国和加拿大,人口老化和医疗保健支出的增加正在推动全球对家用和门诊血压计的需求。由于日本和中国等国家的人口老化、高血压盛行率上升以及个人收入水平的提高,使得对健康监测设备的投资成为可能,亚太地区的全球血压计市场有望迅速扩张。由于健康意识较高、医疗保健系统完善以及高血压盛行率较高,欧洲、中东和非洲地区的血压计市场正在扩大,尤其是在欧洲。欧盟的全球血压计市场受到严格的指导方针监管,以确保产品的准确性和可靠性。医疗保健系统中数位健康整合的普及很高,并且显着转向支援物联网的设备,以进行即时监控和针对患者的特定治疗协调。在医疗基础设施改善、医疗旅游业增加以及政府应对非传染性疾病倡议的支持下,中东和非洲呈现温和成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在全球血压计市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对全球血压计市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析也为该领域的竞争性质提供了宝贵的见解,包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对全球血压计市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[183 Pages Report] The Blood Pressure Monitors Market size was estimated at USD 4.46 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 7.77% to reach USD 7.54 billion by 2030.
Blood pressure monitors are devices designed to measure a person's arterial blood pressure. These devices typically provide two critical pieces of information: systolic and diastolic pressure. Systolic pressure is the highest pressure in the arteries when the heart beats and pushes blood through them, while diastolic pressure is the lowest pressure when the heart is at rest between beats. The growth of the blood pressure monitors market is propelled by the growing global prevalence of hypertension, driven by an aging population and increasing rates of obesity and sedentary lifestyles. In addition, there is a growing trend toward preventive healthcare, where individuals are more proactive in managing their health. Increased awareness regarding the importance of early diagnosis and management of hypertension encourages the use of blood pressure monitors at home, further propelling market demand. However, the market for blood pressure monitors is restrained by instances where products are recalled due to functional faults or safety concerns. Such recalls lead to direct financial losses for manufacturers and diminish consumer trust in these devices. Advanced sensor technologies in blood pressure monitors offer significant opportunities for market expansion. These technological advancements can provide real-time feedback and monitor changes over time, making devices more user-friendly and efficient for home and clinical use.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.46 billion |
Estimated Year [2024] | USD 4.81 billion |
Forecast Year [2030] | USD 7.54 billion |
CAGR (%) | 7.77% |
Regional Insights
In the Americas, the growth of the blood pressure monitors market is driven by the high awareness regarding the importance of blood pressure monitoring owing to the prevalence of hypertension and other cardiovascular diseases. The United States and Canada showcase a high demand for home-based and ambulatory blood pressure monitors owing to the aging population and growing healthcare spending. The Asia-Pacific region is showcasing a rapid expansion in the blood pressure monitors market fueled by a large aging population in countries such as Japan and China, rising prevalence of hypertension, and increasing personal income levels, which allow more people to invest in health monitoring devices. In the EMEA region, particularly in Europe, the blood pressure monitor market is expanding owing to high health awareness, well-established healthcare systems, and a high prevalence of hypertension. The blood pressure monitors market in the EU is regulated with strict guidelines ensuring product accuracy and reliability. There is a high prevalence of digital health integration within healthcare systems, with a significant shift towards IoT-enabled devices for real-time monitoring and patient-specific treatment adjustments. The Middle East and Africa are showcasing gradual growth supported by improving healthcare infrastructure, rising medical tourism, and governmental initiatives to tackle non-communicable diseases.
Market Insights
The market dynamics represent an ever-changing landscape of the Blood Pressure Monitors Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Pressure Monitors Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Pressure Monitors Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Apollo Hospitals Enterprise Ltd. Integrates LifeSigns' AI Technology for Enhanced Patient Monitoring
Apollo Hospitals Enterprise Ltd. has joined a strategic partnership with LifeSigns, an innovator in AI-based health monitoring. This alliance equips Apollo Hospitals Enterprise Ltd. with a sophisticated system for continuous, remote monitoring of patient's vital signs such as ECG, blood pressure, and SPO2. The technology functions through wearable biosensors that transmit real-time data to healthcare professionals, enabling them to detect early signs of complications and customize treatment accordingly. This initiative is part of Apollo Hospitals Enterprise Ltd.'s ongoing commitment to digital healthcare transformation, aiming to improve patient outcomes through proactive and precision medical care. [Published On: 2024-01-11]
FDA Clearance Granted to Nanowear Inc.'s Advanced Blood Pressure Monitoring Technology
Nanowear Inc.'s SimpleSense, a nanotechnology-enabled wearable and software platform, has received FDA 510(k) clearance. This AI-enhanced platform operated noninvasively without cuffs, providing continuous blood pressure monitoring and cardiopulmonary diagnostics, which the FDA previously approved. By capturing over 85 unique biomarker data points from the cardiac and pulmonary systems, SimpleSense offers real-time, comprehensive biometric analytics. This aided healthcare professionals in remote patient monitoring by potentially replacing traditional diagnostic devices such as blood pressure lines and digital stethoscopes. [Published On: 2024-01-04]
Sky Labs Inc. Secures USD 15.3 Million in Series C Funding to Advance Hypertension Technology From South Korean Government Institution
Sky Labs Inc., the South Korean health tech company, has successfully secured a Series C investment totaling 20.7 billion won (USD 15.3 million), spearheaded by the South Korean Government Institution. This recent financial boost, raising their total funding to 54.8 billion won (USD 40.5 million), will help to speed up the development and clinical validation of CART BP, their innovative AI-powered ring-type blood pressure monitor. [Published On: 2023-10-17]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Pressure Monitors Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Blood Pressure Monitors Market, highlighting leading vendors and their innovative profiles. These include A&D Medical Inc., Aktiia SA, American Diagnostic Corporation, Asia Connection Co., Ltd., Beurer GmbH, Cascade Healthcare Solutions, Charmcare Co., Ltd., ChroniSense Medical, Ltd., Cofoe Medical Technology Co., Ltd., Delite Surgicals, ForaCare Suisse AG, Garmin Ltd., GE HealthCare Technologies, Inc., GF Health Products, Inc., Guangdong Transtek Medical Electronics Co., Ltd., Halma PLC, Hill-Rom Holdings, Inc. by Baxter International Inc., Huawei Technologies Co., Ltd., ICU Medical, Inc., iHealth Labs Inc., Koninklijke Philips N.V., Masimo Corporation, Microchip Technology Inc., Microlife Corporation, Nihon Kohden Corporation, OMRON Healthcare, Inc., Orient Surgical Company, and Rossmax International Ltd..
Market Segmentation & Coverage